Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
Identifieur interne : 002498 ( Main/Exploration ); précédent : 002497; suivant : 002499Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
Auteurs : N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Source :
- Journal of Hygiene [ 0022-1724 ] ; 1984-04.
Descripteurs français
- KwdFr :
- Adulte, Anticorps antiviraux (analyse), Antigènes viraux (immunologie), Facteurs temps, Grippe humaine (), Grippe humaine (immunologie), Humains, Hémagglutinines virales (immunologie), Japon, Pharynx (immunologie), Sialidase (immunologie), Sous-type H1N1 du virus de la grippe A, Tests d'inhibition de l'hémagglutination, Tests de fixation du complément, Tests intradermiques, Vaccination, Vaccins antigrippaux (immunologie), Virus de la grippe A (immunologie).
- MESH :
- analyse : Anticorps antiviraux.
- immunologie : Antigènes viraux, Grippe humaine, Hémagglutinines virales, Pharynx, Sialidase, Vaccins antigrippaux, Virus de la grippe A.
- Adulte, Facteurs temps, Grippe humaine, Humains, Japon, Sous-type H1N1 du virus de la grippe A, Tests d'inhibition de l'hémagglutination, Tests de fixation du complément, Tests intradermiques, Vaccination.
- Wicri :
- geographic : Japon.
English descriptors
- KwdEn :
- Adult, Antibodies, Viral (analysis), Antigens, Viral (immunology), Complement Fixation Tests, Hemagglutination Inhibition Tests, Hemagglutinins, Viral (immunology), Humans, Influenza A Virus, H1N1 Subtype, Influenza A virus (immunology), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (prevention & control), Intradermal Tests, Japan, Neuraminidase (immunology), Pharynx (immunology), Time Factors, Vaccination.
- MESH :
- chemical , analysis : Antibodies, Viral.
- chemical , immunology : Antigens, Viral, Hemagglutinins, Viral, Influenza Vaccines, Neuraminidase.
- geographic : Japan.
- immunology : Influenza A virus, Influenza, Human, Pharynx.
- prevention & control : Influenza, Human.
- Adult, Complement Fixation Tests, Hemagglutination Inhibition Tests, Humans, Influenza A Virus, H1N1 Subtype, Intradermal Tests, Time Factors, Vaccination.
Abstract
A cold-adapted influenza A virus, CR-37 (H1N1), derived from genetic reassortment between A/Ann Arbor/6/60 (H2N2) cold-adapted variant virus and A/California/10/78 (H1N1) wild-type virus, was tested in Japanese adult volunteers. The CR-37 live virus preparation induced only low-grade clinical reactionsin volunteers for the first 3–4 days after inoculation. Two vaccinees who did not show any antibody changes became febrile (over 38–0 °C). Skin tests using the vaccine preparation and uninfected allantoic fluid were performed, and indicated that one of these two vaccinees was positive for the CR-37 vaccine preparation. A high proportion of the vaccinees whose sera had a haemagglutination-inhibition (HI) antibody titre against thevaccine strain of ≤ 64 before inoculation, seroconverted in both HI and neuraminidase-inhibition (NA1) antibody titrations, and only a few seroconverted in the titration of antibody against type-specific internal antigens. The serological examinations against heterotypic H1N1 variants indicated that the cold-adapted live influenza virus vaccine could induce a broad spectrum of HI antibody reactivity and immunity of long duration.
Url:
DOI: 10.1017/S0022172400064251
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000168
- to stream Istex, to step Curation: 000168
- to stream Istex, to step Checkpoint: 001168
- to stream Main, to step Merge: 002624
- to stream PubMed, to step Corpus: 000523
- to stream PubMed, to step Curation: 000523
- to stream PubMed, to step Checkpoint: 000457
- to stream Ncbi, to step Merge: 001215
- to stream Ncbi, to step Curation: 001215
- to stream Ncbi, to step Checkpoint: 001215
- to stream Main, to step Merge: 002610
- to stream Main, to step Curation: 002498
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers</title>
<author><name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
</author>
<author><name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
</author>
<author><name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
</author>
<author><name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
</author>
<author><name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3B333BD65FEFD81BE595B8FDD2B3DFD2B68933FB</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1017/S0022172400064251</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6GQ-NQ1KPZ7X-M/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000168</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000168</idno>
<idno type="wicri:Area/Istex/Curation">000168</idno>
<idno type="wicri:Area/Istex/Checkpoint">001168</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001168</idno>
<idno type="wicri:doubleKey">0022-1724:1984:Yamane N:serological:evaluation:of</idno>
<idno type="wicri:Area/Main/Merge">002624</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:6707472</idno>
<idno type="wicri:Area/PubMed/Corpus">000523</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000523</idno>
<idno type="wicri:Area/PubMed/Curation">000523</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000523</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000457</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000457</idno>
<idno type="wicri:Area/Ncbi/Merge">001215</idno>
<idno type="wicri:Area/Ncbi/Curation">001215</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001215</idno>
<idno type="wicri:doubleKey">0022-1724:1984:Yamane N:serological:evaluation:of</idno>
<idno type="wicri:Area/Main/Merge">002610</idno>
<idno type="wicri:Area/Main/Curation">002498</idno>
<idno type="wicri:Area/Main/Exploration">002498</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers</title>
<author><name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Present address: Department of laboratory Medicine, Kumamoto University Medical School, 1-1-1, Honjo, Kumamoto 860</wicri:regionArea>
<wicri:noRegion>Kumamoto 860</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Hygiene</title>
<title level="j" type="abbrev">J. Hyg.</title>
<idno type="ISSN">0022-1724</idno>
<imprint><publisher>Cambridge University Press</publisher>
<pubPlace>Cambridge, UK</pubPlace>
<date type="published" when="1984-04">1984-04</date>
<biblScope unit="volume">92</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="231">231</biblScope>
<biblScope unit="page" to="242">242</biblScope>
</imprint>
<idno type="ISSN">0022-1724</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-1724</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antibodies, Viral (analysis)</term>
<term>Antigens, Viral (immunology)</term>
<term>Complement Fixation Tests</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Hemagglutinins, Viral (immunology)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Intradermal Tests</term>
<term>Japan</term>
<term>Neuraminidase (immunology)</term>
<term>Pharynx (immunology)</term>
<term>Time Factors</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Facteurs temps</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Humains</term>
<term>Hémagglutinines virales (immunologie)</term>
<term>Japon</term>
<term>Pharynx (immunologie)</term>
<term>Sialidase (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de fixation du complément</term>
<term>Tests intradermiques</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Viral</term>
<term>Hemagglutinins, Viral</term>
<term>Influenza Vaccines</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Japan</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes viraux</term>
<term>Grippe humaine</term>
<term>Hémagglutinines virales</term>
<term>Pharynx</term>
<term>Sialidase</term>
<term>Vaccins antigrippaux</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>Influenza, Human</term>
<term>Pharynx</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Complement Fixation Tests</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Intradermal Tests</term>
<term>Time Factors</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Facteurs temps</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Japon</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de fixation du complément</term>
<term>Tests intradermiques</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Japon</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">A cold-adapted influenza A virus, CR-37 (H1N1), derived from genetic reassortment between A/Ann Arbor/6/60 (H2N2) cold-adapted variant virus and A/California/10/78 (H1N1) wild-type virus, was tested in Japanese adult volunteers. The CR-37 live virus preparation induced only low-grade clinical reactionsin volunteers for the first 3–4 days after inoculation. Two vaccinees who did not show any antibody changes became febrile (over 38–0 °C). Skin tests using the vaccine preparation and uninfected allantoic fluid were performed, and indicated that one of these two vaccinees was positive for the CR-37 vaccine preparation. A high proportion of the vaccinees whose sera had a haemagglutination-inhibition (HI) antibody titre against thevaccine strain of ≤ 64 before inoculation, seroconverted in both HI and neuraminidase-inhibition (NA1) antibody titrations, and only a few seroconverted in the titration of antibody against type-specific internal antigens. The serological examinations against heterotypic H1N1 variants indicated that the cold-adapted live influenza virus vaccine could induce a broad spectrum of HI antibody reactivity and immunity of long duration.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
</noRegion>
<name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
<name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
<name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
<name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
<name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002498 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002498 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:3B333BD65FEFD81BE595B8FDD2B3DFD2B68933FB |texte= Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers }}
This area was generated with Dilib version V0.6.33. |